6F
DNA icon

626 Financial’s Ginkgo Bioworks DNA Stock Holding History

626 Financial’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-478
Closed -$32.3K – 108
2023
Q4 		$32.3K Sell
478
-35
-7% -$2.14K 0.02% 103
2023
Q3 		$37.2K Sell
513
-1,175
-70% -$93.9K 0.03% 105
2023
Q2 		$126K Sell
1,688
-81
-5% -$4.79K 0.08% 107
2023
Q1 		$94.1K Buy
1,769
+610
+53% +$38.7K 0.06% 110
2022
Q4 		$78.3K Sell
1,159
-75
-6% -$6.9K 0.05% 106
2022
Q3 		$154K Buy
1,234
+1
+0.1% +$119 0.12% 91
2022
Q2 		$118K Buy
+1,233
New +$150K 0.09% 97
2022
Q1 		– Sell
-622
Closed -$207K – 108
2021
Q4 		$207K Buy
+622
New +$295K 0.13% 103

Other funds holding DNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return